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Because of the potential roles of the primo vascular system (PVS) in cancer metastasis,
immune function, and regeneration, understanding the molecular biology of the PVS is
desirable. The current state of PVS research is comparable to that of lymph research prior
to the advent of Lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1). There is
very little knowledge of the molecular biology of the PVS due to difficulties in identifying
and isolating primo endothelial cells. Present investigations rely on the morphology and
the use of differential staining procedures to identify the PVS within tissues, making
detailed molecular studies all but impossible. To overcome such difficulties, one may
emulate the explosive development of lymph molecular biology. For this purpose, there
is a need for a reliable method to obtain PVS specimens to initiate the molecular investi-
gation. One of the most reliable methods is to detect the primo vessels and primo nodes
afloat in the lymph flow. The protocols for observation of the PVS in the large lymph ducts
in the abdominal cavity and the thoracic cavity were reported earlier. These methods
require a laparectomy and skillful techniques. In this work, we present a protocol to iden-
tify and harvest PVS specimens from the lymph ducts connecting the inguinal and the axil-
lary nodes, which are located entirely in the skin. Thus, the PVS specimen is more easily, Nano Primo Research Center, Advanced Institute of Convergence Technology, Seoul National Uni-
on 443-270, Republic of Korea.
. Bae), kssoh@snu.ac.kr (K.S. Soh).
ually to this work.
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338 S.J. Jung et al.obtainable. This method is a stepping-stone toward development of a system to monitor
migration of cancer cells in metastasis from a breast tumor to the axillary nodes, where
cancer cells use the PVS as a survival rope in hostile lymph flow.1. Introduction and the thoracic cavities [19,20]. Recently, we developed a
new method to detect the PVS in the lymph ducts in skin,In comparison with the blood vasculature, little is known
about the detailed working of the lymphatic system, which
is an important limb of the immune system, forming a
network of lymph nodes where naı¨ve lymphocytes are
brought into contact with antigen-presenting cells to
initiate primary immune responses [1]. Furthermore, lym-
phatics are major paths for metastasis in common cancer,
such as breast and colorectal carcinomas, which are
initially disseminated through the lymph nodes [2,3].
Although lymphatics are very important for the func-
tioning of the immune systems, only a rudimentary under-
standing of the molecular biology of lymphatics exists due
to technical difficulties in identifying lymph vessels within
tissues and in isolating pure cultures of lymphatic endo-
thelial cells for detailed characterization [4]. The first
breakthrough came from the identification of the vascular
endothelial growth factor-C (VEGF-C) as a specific lym-
phangiogenic growth factor [5,6]. This discovery eventually
led to the identification of LYVE-1, a receptor for the
extracellular matrix mucopolysaccharide hyaluronan,
which is preferentially expressed on the lymphatic endo-
thelium [7e9]. The finding of LYVE-1 opened a new frontier
in the molecular biology of lymphatics.
The lymphatic vasculature forms a second circulatory
system that provides immune protection against foreign
antigens. Recently, the primo vascular system (PVS), a third
circulatory system that corresponds to the anatomical
substance of the classical Qi path of acupuncture was
found. This system was discovered by Bong-Han Kim [10] in
the early 1960s, but was neglected for a long time until
recently rediscovered in various organs of animals by the
Seoul National University group [11,12]. Most surprisingly,
the PVS was in vivo in situ demonstrated in the lymphatic
ducts of rabbits [13] and rats [14], and it was also found in
mice [15]. Its presence had not been noticed earlier
because of its transparency, but was revealed using suitable
staining dyes such as Janus Green B [16], fluorescent
nanoparticles [14], Alcian blue (AB) [17], and 1,10-dio-
ctadecyl-3,3,30,30-tetramethylindocarbocyanine perchlo-
rate (DiI) [18].
The progress in PVS biology is currently slow largely due
to technical difficulties in identifying primo vessels (PVs)
within various tissues. The situation is similar to that of
lymph research prior to the advent of VEGF and LYVE-1.
Earlier and recent investigations relied on applying labo-
rious staining procedures to identify the PVS morphology.
Molecular studies similar to those carried out in lymph
research are needed; otherwise, doing detailed molecular
studies may remain all but impossible.
The purpose of the current work is to provide a detailed
protocol to obtain pure PVS tissue for researchers who
accept the challenge to identify relevant molecules that
may be exploited as markers for the PVS endothelium. In
our previous reports on the protocol for observation of the
PVS, we considered the lymph ducts inside the abdominalthat is, in the ducts connecting the inguinal node (IN) to the
axillary node (AN) [21]. This opened the way to observe the
PVS without a laparectomy, which will make it possible to
monitor PVS state changes by installing a window system in
skin. This system will, in turn, allow for researchers to
study cancer-cell transport along the PVs in lymph ducts
from the breast tumor to ANs.
Themedical relevance of the PVS in cancer and especially
its metastasis was reported by independent teams [22e25].
The PVS inside a lymph vessel froma cancer tissue suggests its
role as a survival rope for the cancer cells in the lymph flow
[24e26]. In addition, the immunological significance of the
PVS was suggested by the abundance of immune cells in the
primo node (PN) with cell populations as mast cells (20%),
eosinophils (16%), neutrophils (15%), lymphocytes (1%),
immature cells (13%), and chromaffin cells (0.3%) [27].
Elucidation of the PVS may, therefore, offer new medical
insights into a spectrumof disease states such as autoimmune
diseases and cancer. Furthermore, the existence of very
small stem-like microcells and their regeneration function
were reported by Bong-Han Kim [10]. Various studies have
confirmed the existence of these microcells [28].
2. Materials
2.1. Reagents
Experimental animals: Rats (Sprague-Dawley, male, 9
weeks old, 260e300 g) were purchased from DooYeol Lab-
oratory Animal Company (Seoul, Korea). The animals were
housed in a constant temperature-controlled environment
(23C) with 60% relative humidity. All animals were exposed
to a 12-hour lightedark cycle and had ad libitum access to
food and water. Procedures involving the animals and their
care conformed to institutional guidelines (Approval No.:
WJIACUC 20130212-1-07).
Anesthesia: Zoletil (Virbac Laboratories, Carros, France),
xylazine (Bayer, Korea).
Contrast agent: AB for PVS staining.
Histology: 40,6-diamidino-2-phenylindole (DAPI) stain-
ing, phalloidin staining, DiI staining, hematoxylin and eosin
(H&E), and Gordon and Sweet’s silver staining.
Immunohistochemistry: Anti EMP-3 antibody (EMP-3)
and von Willebrand factor (vWF). See supplementary
material online for further information.
2.2. Equipment
 Microscopes and light source
 Surgical instruments
 Syringes and filters
 Staining and histology instruments
 Homemade injection tool for precision injection (Fig. 1A).
See supplementary material for further information.
Figure 1 Injection with the homemade injectionmicropipette. (A) The injection syringe set used in the experiments. The syringe set
consisted of a Kovax-Syringe (26 G  1/2 in.; white arrow) and a Luer of a scalp-vein set (24 G 3/4; arrowhead). The Luer held the
micropipettemadeof a glass capillary (black arrow). (B) Stereomicroscopic image of dye injection. The inguinal lymphnode (circled bya
broken line)was heldwith a forceps and the glass capillary (black arrow)was inserted into the node and Alcian bluewas slowly injected.
Primo Vascular System in Lymph Duct 339Step 1: Method to make a micropipette
(1) Prepare thin-walled glass capillaries that have equal
lengths of 76 mm (3 in.) and outer and inner di-
ameters of 1.5 and 1.12 mm, respectively.
(2) Set a capillary on a puller (PP-830; Narishige Inter-
national USA, Inc., East Meadow, NY).
(3) Set the temperature to 73C by adjusting the Number
1 heater knob on the puller.
(4) Press START to activate the PP-830. The key point is
that the heater value is set relatively high to melt a
large amount of glass. The glass capillary is heated by
the filament in the heater and is pulled by the load of
the weight blocks. It is important to keep the length
of each micropipette constant at 3 cm.
(5) Keep the long, thin micropipettes that were produced
for injection purposes in a safe area for later use.
Step 2: Method to make a front-tip connector
(6) Use a scalp-vein set (24 G 3/4; Becton, Dickinson and
Company, East Rutherford, NJ, USA) to make a holder
for the micropipette.
(7) Cut the distal end of the set; the cutting line is the
joining point of the thin cannula attached to a female
Luer. This Luer will hold the micropipette.
(8) Carefully insert the micropipette prepared in Step 1
into a small hole in the front tip of the Luer.
Step 3: Method to make a complete injection syringe
(9) Prepare a disposable 1-mL (26 G  1/2 in.) Kovax-
Syringe (sterile hypodermic syringe).
(10) Remove the needle tip from a syringe and replace it
with the micropipette’s Luer connector.
CRITICAL STEP
Load the AB staining dye prior to attaching the
connector to the tip of the syringe.
2.3. Reagent setup
 Animals
 Phosphate-buffered saline (PBS) solution
 AB staining dye (0.2%): Combine 0.014 g of AB powder
with 7 mL of boiled hot 1  PBS solution to make a 0.2%
AB staining dye.Steps:
(1) To inhibit the coagulation of the AB powder mix with
the 1  PBS solution, first boil 10 mL of the 1  PBS
solution at a high temperature (100C) until its vol-
ume is reduced to 7 mL. Store the solution in a 10-mL
Falcon tube.
(2) To this hot PBS solution, add 0.014 g of AB powder and
mix the contents by gently inverting the tube four to
six times with continuous motion. Do not shake with a
vortex machine tool. A blue solution is formed.
(3) Filter this blue solution using a 0.22-mm syringe filter
attached to a 10-mL syringe.
(4) Check the pH of this solution to test an appropriately
validated method. When the pH is between 6.2 and
6.4, load the AB solution into a specialized injection
syringe (previouslymade) prior to injection into the IN.
 DAPI
 Phalloidin
 DiI
 Harris’ H&E
 Gordon and Sweet’s silver staining
 EMP-3
 vWF
 Immunohistochemical blocking solutionSee supplementary material online for further information.
2.4. Equipment setup
Dissecting instruments: Two large scissors, small micro-
scissors, two large forceps, two microdissecting tweezers,
small forceps, one pair of fine straight forceps, one pair of
curved forceps, one pair of microdissecting straight forceps,
one pair of angular microdissecting forceps, 31-G insulin
syringes, and a specialized homemade 1-mL syringe.
CAUTION
(1) All instruments and other equipment must be steril-
ized prior to use.
(2) In addition to sterile microdissecting instruments, two
sets of sterile instruments should be used. Separate
sets are used for the skin and peritoneal wall and for
dissection and extraction of the primo system in the
lymph vessels to reduce the chances of contamination
while proceeding through the tissue layers.
340 S.J. Jung et al.3. Procedure
An overview and time distribution of the entire procedure
are as follows:
 Steps 0: Preparing the animal prior to surgery (time: 20
minutes)
 Steps 1e6: Detecting the PVS network (time: 2e3 hours)
 Step 7: Harvesting the PVS (time: 1e2 hours)
 Step 8: Identifying the PVS (time: 40 minutes)
Steps 0: Preparing the animal prior to surgery (time: 20
minutes)
Animal preparation
(1) Anesthetize the rat with an intramuscular injection
of a mixture of Zoletil (0.3 mL) and xylazine (0.1 mL)
using a 1-mL sterile hypodermic syringe.
(2) Remove the hair from the abdominal and the flank/
hip areas using a pet specialty cordless trimmer/
shaver. Remove the remaining loose hair using an
alcohol swab and patting the area with tape.
(3) Fix the rat with its head away from the operator by
taping its feet to the operating surgical board. To
protect the rat’s eye from light exposure, cover the
eye with gauze prior to surgery.
(4) Position the fiber optic illuminators for optimum
illumination. Adjust the stereomicroscope and the
monitoring system for optimal observation.
CAUTION
Throughout the procedure, the rat is continually moni-
tored for anesthetic state by a toe-pinch method and
respiratory rate examination.Figure 2 The lymph duct from the inguinal node to the axillary no
skin. (A) The illustration of the lymph ducts and nodes around th
became blue as the Alcian blue flowed through the lymph duct. (C)
lymph duct around the epigastric vein (red thick arrows). (E) The m
the lymph duct. Notice that the primo vessel was much thinner tha
whereas that of the primo vessel was 28 mm.Steps 1e6: Detecting the PVS network (Time: 2e3 hours)
1. Rat skin incision around the IN
(1.1) During the entire surgical procedure, ensure the
exposed tissue is always kept wet with equilibrated
warmed PBS solution.
(1.2) Place the rat on a clear surgical board in a supine
frog-leg position. Attach the rat by taping each
footpad to the board. Check the body temperature
of the rat during the procedure.
(1.3) Place the rat under a dissecting stereomicroscope.
(1.4) Make a 2-cm skin midline incision up and down
from the navel along the ventral surface of the
abdominal cavity and retract the skin toward the
rat’s spinal column.
CRITICAL STEP
Make the incision as small as possible to minimize the
damage to the rat.
(1.5) After the skin is retracted, pin the skin to the
surgery board.
(1.6) Place one or two rolled sheets of clean gauze un-
derneath the skin so that the IN is easier to locate.
2. Locating the IN
(2.1) Superficial lymph nodes, such as the IN, are bilateral
and situated close to the bifurcation of the superfi-
cial epigastric vein. INs are often hidden in the
connective tissue and fat that encircle the superfi-
cial epigastric vein, and therefore, careful obser-
vation is required tofind thenodes. If you still cannot
locate the IN, slightly pull the rat’s lower limb on the
side toward your body to extend its position (Fig. 2).
(2.2) Remove the thin layer of connective tissue over-
laying the area around the IN. Next, clear thede, which was located near the superficial epigastric vein in the
e superficial epigastric vein in the skin. (B) The axillary node
The inguinal node into which Alcian blue was injected. (D) The
agnification view of the blue-stained primo vascular system in
n the lymph duct. The thickness of the lymph duct was 290 mm,
Primo Vascular System in Lymph Duct 341adipose tissue overlaying and surrounding the IN
until the microvascular bed is exposed. The su-
perficial epigastric vein lays adjacent to the IN and
is commonly overlayed by the venules. It is
important not to injure the vessels by placing too
much force on them when manipulating the adi-
pose and connective tissues around them.
(2.3) INs are of variable size in different rats, and are
usually oval (shaped as a small pea or bean).
Lymph nodes are normally yellowish brown or tan
and appear slimy. According to our data, the INs
are approximately 2.5 mm in width and 4.5 mm in
length. The lymph nodes of normal rats are small
and difficult to distinguish from the surrounding
adipose and connective tissues, and therefore, it is
necessary to find lymph vessels connected to INs. A
network of lymph vessels connected to INs along
the superior epigastric vein can be observed.
3. Injecting AB into the IN
(3.1) After exposing the IN, hold the tip of node and
slightly lift it up with smooth-tip forceps toward
your body to ease the injection.
(3.2) The prepared 0.2% AB dye is loaded in a syringe
specially designed by our team for reducing the
rate of blood vessels puncturing, which causes
leakage of blood inside the node. Inject the loaded
dye, approximately 0.2e0.4 mL, into the node at a
slow rate. As stated earlier, INs are usually found in
groups of two to three nodes.
(3.3) Depending on the injection point in the node,
staining dye travels in separate ways along
different lymph vessels. We recommend choosing
the upper most IN among the group of nodes for
injecting the dye, so that it reaches the ANs. When
the staining dye is injected into the middle or the
undermost INs, it will travel toward the abdominal
area through a network of lymph vessels.
CRITICAL STEPS
(1) Slow and smooth needle injection is needed.
(2) Slow injection of AB into the IN: inject the AB with a
maximum of 0.03 mL/4 minutes into the nodes on
each side of the skin. Slower is better.
(3) Wait for approximately 3e5 minutes until the IN is
stabilized.
(4) Slowly and gently pull the needle out after injection.
(3.4) Check the rat’s respiratory rate again because
without spontaneous pumping, movement of
the dye within the lymphatic vessel is limited to
a short distance from the injection site.4. Visualization of the PVS
(4.1) Put the skin back to the original position to keep
the body warm.
(4.2) Stop the lymphflow from the IN to the AN in order
to induce proper staining of the PVS by tying the
upper chest with a string for 30 minutes.
(4.3) Release the tie after 30 minutes for proper
lymph fluid flow.
(4.4) Wash the residual AB staining in the lymph ducts
by natural flow. This takes approximately 1 hour
and 30 minutes.CRITICAL STEPS
(1) Finding the optimal time and speed for the AB to be
absorbed by the PVS in the lymph during the flow-
blocking period is critical. This is usually approxi-
mately 30 minutes. This process is critical because
the PVS will absorb the AB during this period. Various
techniques can be used to slow down the lymph flow:
put a pillow under the shoulder to maintain a slanted
position. Put a weight on the skin near the AN
entrance. Tie the upper chest to keep pressure on the
lymph ducts. Other methods can also be tried.
(2) Another optimal condition is to make the lymph
flow fast during the washing period to clean the
lymph ducts. Otherwise, the lymph ducts will be
stained blue. This is critical because the remnant
AB should be completely cleared from the lymph
flow.
5. Observation of the lymph ducts
(5.1) Second incision of the skin. Recall Steps 1.4e1.6.
The second incision starts from the end point of the
first cutting near the navel approximately 4 cm
toward the cranium. Overturn the skin toward the
spinal column and pin it to a surgical board for clear
observation of the lymph ducts.
(5.2) Tracing lymph ducts along the epigastric vein. The
main lymph duct to observe is located along the
superior epigastric vein. It connects the IN to the
AN, and most of the time, it branches out to the
sides on the skin, and therefore, extra care is
needed, especially when connective tissue is
removed for observation.
(5.3) Locating the AN. The AN is easily identifiable due
to the blue color of the AB, which flows into the
lymph ducts from the IN. ANs are regularly situ-
ated internal to the deep fascia of the upper
limb; more specifically, they are present in the
axillary fossa. Brachial and retroscapular lymph
nodes, in proximity to the angle of the scapula,
are found in groups of more than one large lymph
node.
6. Observation of the PVS
(6.1) When the conditions are satisfied (e.g., washing
time, concentration of AB, temperature), a large
network of the PVs and PNs appears floating inside
the clear lymph vessels between the IN and the AN.
The PV is more prominently stained with AB than
the lymphatic duct. A stereomicroscope examina-
tion along the lymph ducts in the skin will show
free-floating, thin, blue PV lines inside the washed
lymph vessels.
(6.2) Try to find the PNs. A PN is irregularly located along
the PV, and it looks like a thicker, oval blob
(Fig. 3A).
(6.3) The PV forms a network structure with branches. Try
to observe as many PVS specimens as possible
(Fig. 3B).
(6.4) A PV often passes lymph valves, and thus it should
be observed as carefully as possible (Fig. 3C).
(6.5) PVs in efferent ducts flowing from the IN should be
observed carefully (Fig. 3D).
Figure 3 Stereomicroscopic images of primo vascular system taken in situ. (A) A network of branches of primo vessels (branching
points are indicted by arrows). In regions where the lymph ducts branched, the primo vessels also branched. (B) A primo vessel
passed the lymph valve (broken lines) of a lymph duct (double arrows). (C) The blue-stained primo vessel (thick arrows) that was in
the efferent lymph duct (double arrows) emanating from the inguinal node (circled by a broken line). (D) The primo vessel (thick
arrows) entered the axillary node (circled by a broken line). It was in the afferent lymph duct (double arrows) and branched. The
lymph node was only partially stained. (E) The primo vessel was barely stained and the two primo nodes were easily noticeable
(arrows) in the lymph duct (double arrows). (F) The image showed the primo vessel that was cut and coiled (thick arrows) due to its
elasticity.
342 S.J. Jung et al.(6.6) PVs in afferent ducts flowing to the AN should be
observed carefully (Fig. 3E).
CRITICAL STEPS
(1) The PV is sometimes only partially stained, and a few
blue dots appear sporadically. The PV is transparent
and hard to notice between these blue dots. How-
ever, the thread is continuous, and the uncolored
parts are better for an analysis of the genuine PVS
(Fig. 3F).
(2) When the washed lymph duct is shaken gently but
briskly by touching the outside with a smooth-tip
forceps, the PVS lines floating inside a lymph duct
move like a wave in lymph fluid and shine, so they are
best detected through straightforward (but careful )
real-time observation.CRITICAL STEPS
On-site criteria to discern the PVS candidate from
artifacts.
(1) Shake the lymph ducts gently, and the blue thread-
like structure should remain unbroken. The aggre-
gates of dye are easily broken. The PVS undulates in
this process and remains intact as shown in the
supplementary material online.
(2) The diameter of the PV is uniform and is approxi-
mately 20e30 mm.
(3) When a PV is cut by accident inside the lymph duct,
it will roll up due to its elasticity and can be easily
pulled out from the duct without breaking when the
sample is extracted.
Step 7: Harvesting the PVS (Time: 1e2 hours)
Primo Vascular System in Lymph Duct 3437. Isolation of the lymph ducts and PVS specimens
(7.1) After the PVS has been detected in the lymph
ducts, the lymph ducts with the PVS in them can be
isolated in two alternative methods.
Method 1: (Fresh Sample)
(7.2) Remove the whole lymph nodes and ducts (i.e., the
IN, AN, and the ducts between them) containing
the PVS from the skin with microscissors under a
stereomicroscope.
(7.3) Carefully incise the lymph vessel along the vessel’s
wall using microscissors.
(7.4) Use sharp-ended curved forceps to hold both side
splits of a lymph vessel and tear the vessel apart
toward the direction of the AN. Be careful not to
damage the PVS specimen floating inside the vessel
during this procedure.
(7.5) When an appropriate length of PVS specimen has
been exposed, gently pull it out toward your body.
Because a PV is elastic, it can be pulled out by
applying constant force. This specimen is ready for
identification using a histological analysis.
Method 2: (Fixed Sample)
(7.1) Remove the whole lymph nodes and ducts con-
taining the PVS from the skin.
(7.2) Fix the whole isolated samples with either 4% Para-
formaldehyde, a fixation solution (PFA) solution or
10% neutral phosphate-buffered formalin solution
for 1 day or 2 days for further analysis. Fixed samples
are to be stored at 4C in a refrigerator until use.
(7.3) Wash the fixed sample with 1  PBS solution three
times and prepare a glass slide with 1 drop of
1  PBS solution to protect the sample from drying
during the procedure.
(7.4) Place the fixed whole sample on a slide. Use two
31-G insulin syringe needle tips to cut and tear the
lymph duct to extract the PVS specimen. A useful
tip for isolating the PVS from the duct is to cut one
end of the lymph vessel obliquely at 45 from the
skin surface, which will give space for separation.
CRITICAL STEPS
(1) Tear the lower end of a harvested lymph vessel with a
sharp-ended forceps and expose the end part of the
PVS inside the vessel. Gently pull out the PV.
(2) The following is an on-site checklist for identification
of the PVS from artifacts such as the coagulation of
AB with lymph fluids in a string-like form: (i) The PVS
is a floating thread-like structure not attached to the
lymph walls. (ii) The PVS thread is elastic, but the AB
coagulation is not and is, therefore, easily broken.
(iii) The diameter of a PV is approximately 20e30 mm.
(iv) The PNs are thicker parts of the PV, and their
numbers, thicknesses, and lengths vary. (v) The PVs
pass through the lymph valves. (vi) The PVs branch
when the lymph vessels branch. (vii) If the diameter
of a PV is larger than 50 mm, the PV has most likely
adhered with blood cells or lymphocytes.
Step 8: Identifying the PVS (Time: 40 minutes)8. Identification of the PVS with DAPI and phalloidin
(8.1) Gently wash the PVS specimen in a drop of 1  PBS
solution, place it on a clean glass slide, and then
flatten the tissue slightly. Perform this step under a
stereomicroscope.
(8.2) Phase contrast microscope: Check the bundle
structure of the PV.
(8.3) DAPI: Check the alignment of rod-shaped nuclei of
the endothelial cells lining the primo subvessel.
Stain the specimen with Prolong Gold Antifade
reagent with DAPI again for 10 minutes to examine
the nuclei in the endothelial cells of the PV. When
applying the DAPI, mix thoroughly, but take care
not to create too many bubbles. Drain excess so-
lution from the slide. Apply two separate drops of
Gel MounteDAPI on the sections, and lower the
cover slip on the sections. Allow the slide to be in
darkness for a few minutes, and seal the cover slip
with a transparent manicure.
(8.4) Phalloidin: Observe the F-actin distribution in
cells. The F-actin molecules should be along the
PV. To show the F actins in the endothelial cells of
the PV, stain the specimen with 6.6 mM phalloidin
for 20 minutes, followed by three PBS washes.
CAUTION
Avoid light on the sample while staining with phalloidin
and DAPI.
(8.5) Examine the specimens with a fluorescence phase
contrast microscope (Olympus BX51, Olympus,
Seoul, Korea) and a confocal laser scanning mi-
croscope (C1 plus, Nikon, Tokyo, Japan) to observe
F actins and the rod-shaped nuclei (Fig. 4AeC).
CRITICAL STEPS
(1) Morphological characteristics of the PV are its di-
ameters (20e30 mm), bundle structure of several
subvessels, rod-shaped nuclei (length: 15e20 mm) of
endothelial cells aligned in broken parallel curves,
and sometimes the presence of DNA-containing
granules inside subvessels. F actins are also aligned
along the PV.
(2) Nonpure, thick samples have coagulated lympho-
cytes surrounding the PV.4. Anticipated results
4.1. Characteristics of the PVS
If the genuine characteristics of the PVS are to be proven,
the following series of histological analysis must be per-
formed. Because these procedures are conventional tech-
niques, their details have been omitted in this paper.
 H&E: It shows the cytoplasm and nuclei of the PVS.
 DiI: The signals show the membrane wrapping the PVS,
demonstrating its unique independent identities. Coag-
ulation or aggregated lymphocytes or fibrins do not have
a wrapping membrane.
Figure 4 (A) A phase contrast image of a primo vessel extracted from the lymph vessel. The blue color is due to Alcian blue
staining. (B) Distribution of nuclei in the primo vessel stained with 40,6-diamidino-2-phenylindole. Rod-shaped nuclei were aligned
along the primo vessel [The boxed region in (A)]. (C) Distribution of F actins of cells in the primo vessel stained with phalloidin.
They are aligned along the primo vessel [The boxed region in (A)].
344 S.J. Jung et al. Gordon and Sweet’s silver staining: It shows the pres-
ence of reticular-type collagens in the PVS. The inner
wall of the lymph ducts does not have such fibers.
 VWF: It shows the presence of endothelial cells in the
PVS.
 EMP-3: It shows the presence of epithelial cells forming
the outer part of the PVS.
 LYVE-1: Its negative expression proves that the PVS is
different from a lymph vessel.
 CD34: Its negative expression shows that the PVS is
different from blood vessels.
Further evidence of a wrapping membrane using an
electron microscope was reported earlier and was
confirmed with atomic force microscopy data.4.2. Future progress
The large lymph ducts along the caudal vena cava of a
rabbit [19] and a rat [20] are target sites to search for a PVS
floating in the lymph flow. For this purpose, a laparectomy
was performed. The procedure caused severe damage to
the animal, which was euthanized after observation of the
PVS. In this current work, the lymph ducts were in the skin
and could be observed without damaging essential organs
of the animal and with minimal skin incision. The lymph
ducts connecting the ANs are particularly interesting
because metastasis of breast cancer occurs through these
ducts. The current method is the first step toward moni-
toring the PVS states in these ducts through a window
installed in the skin. Taking just one example of medical
applications with a monitoring system, we can trace the
cancer cells migrating through the PVS as a safe fording
rope in the hostile lymph flow [24].
In addition to AB, DiI can also be used to visualize the
PVS in lymph ducts. In the current report, we omitted the
DiI method because it is essentially similar to the AB pro-
tocol. However, the two methods have different advan-
tages. An Alcian-blue-stained PVS is detectable with
halogen lamp illumination, whereas a DiI-stained PVS is only
visible with a fluorescent microscope, which requires
extensive work. The latter method can be used for studying
the optical properties of the PVS, whereas the former
method is not suitable because of their color.Once the optical properties of the PVS are established, it
is possible to devise methods and instruments to observe
the PVS in lymph ducts without any staining. Next, moni-
toring of the PVS will be realizable by applying an optical
method through the window installed in the skin. The
protocol established in this work provides interested re-
searchers with methods to obtain PVS specimens that can
be used to elucidate the molecular biology of the PVS by
identifying and isolating primo endothelial cells.
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